Pages that link to "Q69735551"
Jump to navigation
Jump to search
The following pages link to Pentostatin in the treatment of advanced hairy cell leukemia (Q69735551):
Displaying 32 items.
- Hairy cell leukaemia (Q33490838) (← links)
- Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia (Q33844299) (← links)
- Pentostatin in the treatment of hairy-cell leukemia (Q34187582) (← links)
- Therapeutic advances in the treatment of hairy cell leukemia (Q34217825) (← links)
- Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years (Q34462315) (← links)
- Advances in the treatment of hairy-cell leukaemia (Q35062368) (← links)
- My treatment approach to hairy cell leukemia (Q36399120) (← links)
- New Chemotherapeutic Agents for Non-Hodgkin’s Lymphomas (Q36692577) (← links)
- Hairy cell leukaemia: The role of alpha interferon (Q36997857) (← links)
- Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases. (Q37424784) (← links)
- Recombinant immunotoxins for the treatment of chemoresistant hematologic malignancies. (Q37581788) (← links)
- Hairy cell leukemia-new genes, new targets (Q38124726) (← links)
- The role of interferons in the treatment of malignant neoplasms (Q38208932) (← links)
- Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders (Q40385554) (← links)
- The optimal management of hairy cell leukaemia (Q40403299) (← links)
- Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias (Q40479351) (← links)
- Hairy cell leukemia: New understanding of biology and treatment (Q40485478) (← links)
- Interferon-alpha in malignant and viral diseases. A review (Q40485713) (← links)
- Advances in therapy for hairy cell leukemia (Q40487421) (← links)
- Ocular toxicity and cancer chemotherapy. A review (Q41137774) (← links)
- Atypical prolymphocytic variant of hairy-cell leukemia: case report and review of the literature (Q41189240) (← links)
- Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial (Q42291047) (← links)
- Reduced dose pentostatin for initial management of hairy cell leukemia patients who have active infection or risk of hemorrhage is safe and effective (Q43087332) (← links)
- Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients (Q44279389) (← links)
- Transport of 2′-deoxycoformycin in human leukemie and lymphoma cells (Q44419831) (← links)
- A phase II investigation of pentostatin in metastatic malignant melanoma (Q45894338) (← links)
- Fludarabine phosphate in refractory hairy cell leukemia (Q67688769) (← links)
- Phase II study of 2'-deoxycoformycin in patients with renal cell carcinoma. A National Cancer Institute of Canada Clinical Trials Group study (Q67841947) (← links)
- Hairy cell leukemia (Q74267091) (← links)
- Multicenter retrospective analysis regarding the clinical manifestations and treatment results in patients with hairy cell leukemia: twenty-four year Turkish experience in cladribine therapy (Q85956879) (← links)
- Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia (Q89777348) (← links)
- Antimetabolites (Q93510105) (← links)